Research ArticleCardiology
Evaluation of Antiatherogenic Properties of Ezetimibe Using 3H-Labeled Low-Density-Lipoprotein Cholesterol and 99mTc-cAbVCAM1–5 SPECT in ApoE−/− Mice Fed the Paigen Diet
Laurent S. Dumas, François Briand, Romain Clerc, Emmanuel Brousseau, Christopher Montemagno, Mitra Ahmadi, Sandrine Bacot, Audrey Soubies, Pascale Perret, Laurent M. Riou, Nick Devoogdt, Tony Lahoutte, Gilles Barone-Rochette, Daniel Fagret, Catherine Ghezzi, Thierry Sulpice and Alexis Broisat
Journal of Nuclear Medicine July 2017, 58 (7) 1088-1093; DOI: https://doi.org/10.2967/jnumed.116.177279
Laurent S. Dumas
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
3Advanced Accelerator Applications, Saint-Genis-Pouilly, France
François Briand
4Physiogenex, Labège, France
Romain Clerc
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
4Physiogenex, Labège, France
Emmanuel Brousseau
4Physiogenex, Labège, France
Christopher Montemagno
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
Mitra Ahmadi
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
Sandrine Bacot
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
Audrey Soubies
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
Pascale Perret
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
Laurent M. Riou
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
Nick Devoogdt
5ICMI, Vrije Universiteit Brussel, Brussels, Belgium; and
Tony Lahoutte
5ICMI, Vrije Universiteit Brussel, Brussels, Belgium; and
Gilles Barone-Rochette
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
6CHRU Grenoble, Hôpital Michallon, Grenoble, France
Daniel Fagret
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
6CHRU Grenoble, Hôpital Michallon, Grenoble, France
Catherine Ghezzi
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
Thierry Sulpice
4Physiogenex, Labège, France
Alexis Broisat
1INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France
2UGA, Université Grenoble Alpes, Grenoble, France
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 58, Issue 7
July 1, 2017
Evaluation of Antiatherogenic Properties of Ezetimibe Using 3H-Labeled Low-Density-Lipoprotein Cholesterol and 99mTc-cAbVCAM1–5 SPECT in ApoE−/− Mice Fed the Paigen Diet
Laurent S. Dumas, François Briand, Romain Clerc, Emmanuel Brousseau, Christopher Montemagno, Mitra Ahmadi, Sandrine Bacot, Audrey Soubies, Pascale Perret, Laurent M. Riou, Nick Devoogdt, Tony Lahoutte, Gilles Barone-Rochette, Daniel Fagret, Catherine Ghezzi, Thierry Sulpice, Alexis Broisat
Journal of Nuclear Medicine Jul 2017, 58 (7) 1088-1093; DOI: 10.2967/jnumed.116.177279
Evaluation of Antiatherogenic Properties of Ezetimibe Using 3H-Labeled Low-Density-Lipoprotein Cholesterol and 99mTc-cAbVCAM1–5 SPECT in ApoE−/− Mice Fed the Paigen Diet
Laurent S. Dumas, François Briand, Romain Clerc, Emmanuel Brousseau, Christopher Montemagno, Mitra Ahmadi, Sandrine Bacot, Audrey Soubies, Pascale Perret, Laurent M. Riou, Nick Devoogdt, Tony Lahoutte, Gilles Barone-Rochette, Daniel Fagret, Catherine Ghezzi, Thierry Sulpice, Alexis Broisat
Journal of Nuclear Medicine Jul 2017, 58 (7) 1088-1093; DOI: 10.2967/jnumed.116.177279